123 related articles for article (PubMed ID: 16201192)
1. [Clinical value of preserving intercostal-brachial nerve during breast cancer operations].
Fan Z; Song Z; Li H
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):773-4. PubMed ID: 16201192
[TBL] [Abstract][Full Text] [Related]
2. [Methods of preserving intercostobrachial nerve during breast cancer operation and its clinical value].
Wei WD; Wang X; Rong TH; Huang ZF; Li BJ
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1136-8. PubMed ID: 16194314
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized controlled trial of preservation of the intercostobrachial nerve during axillary node clearance for breast cancer.
Abdullah TI; Iddon J; Barr L; Baildam AD; Bundred NJ
Br J Surg; 1998 Oct; 85(10):1443-5. PubMed ID: 9782034
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of intraoperational preservation of intercostobrachial nerve for patients with breast cancer].
Cao XC; Zhao K; Ning LS
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):549-50. PubMed ID: 17147126
[No Abstract] [Full Text] [Related]
5. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
6. Randomized clinical trial comparing level II and level III axillary node dissection in addition to mastectomy for breast cancer.
Tominaga T; Takashima S; Danno M
Br J Surg; 2004 Jan; 91(1):38-43. PubMed ID: 14716791
[TBL] [Abstract][Full Text] [Related]
7. [Lesion of the intercostobrachial nerve].
Klingelhöfer J; Conrad B
Nervenarzt; 1985 Aug; 56(8):449-52. PubMed ID: 4058618
[TBL] [Abstract][Full Text] [Related]
8. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
[TBL] [Abstract][Full Text] [Related]
9. [Tactile sensibility in arm of women subjected to the axillary lymph node dissection for breast cancer].
Santos MS; Panobianco MS; Mamede MV; Meirelles MC; Barros VM
Rev Bras Ginecol Obstet; 2009 Jul; 31(7):361-6. PubMed ID: 19838582
[TBL] [Abstract][Full Text] [Related]
10. [Technique investigation of endoscopic axillary lymph node dissection by liposuction].
Guo MQ; Jiang J; Yang XH; Fan LJ; He QQ; Zhang Y
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):757-61. PubMed ID: 16836925
[TBL] [Abstract][Full Text] [Related]
11. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
12. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
13. Decreasing arm morbidity by refining axillary surgery in breast cancer.
Ponzone R; Cassina E; Tomasi Cont N; Biglia N; Sismondi P
Eur J Surg Oncol; 2009 Apr; 35(4):335-8. PubMed ID: 18715747
[No Abstract] [Full Text] [Related]
14. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study.
Albert US; Koller M; Kopp I; Lorenz W; Schulz KD; Wagner U
Breast Cancer Res Treat; 2006 Dec; 100(3):285-92. PubMed ID: 16710790
[TBL] [Abstract][Full Text] [Related]
15. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
Goyal A; Newcombe RG; Chhabra A; Mansel RE
Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
[TBL] [Abstract][Full Text] [Related]
16. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
Nesvold IL; Dahl AA; Løkkevik E; Marit Mengshoel A; Fosså SD
Acta Oncol; 2008; 47(5):835-42. PubMed ID: 18568481
[TBL] [Abstract][Full Text] [Related]
17. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
18. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.
Zavagno G; De Salvo GL; Scalco G; Bozza F; Barutta L; Del Bianco P; Renier M; Racano C; Carraro P; Nitti D;
Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523
[TBL] [Abstract][Full Text] [Related]
19. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
Lucci A; McCall LM; Beitsch PD; Whitworth PW; Reintgen DS; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Giuliano AE;
J Clin Oncol; 2007 Aug; 25(24):3657-63. PubMed ID: 17485711
[TBL] [Abstract][Full Text] [Related]
20. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
